Related Experiment Videos
[Metastatic thyroid carcinoma with hyperthyroidism (author's transl)]
Annales D'Endocrinologie
|March 1, 1977
Summary
Radioiodine therapy effectively treated thyroid carcinoma metastasis in bones and liver. High-dose radioactive iodine (131I) administration led to clinical regression of metastases and hypothyroidism.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Thyroid carcinoma can metastasize to distant organs like bone and liver.
- Radioiodine uptake in metastatic lesions indicates functional thyroid tissue, a target for therapy.
- Thyrotoxicosis can occur in patients with metastatic thyroid cancer.
Observation:
- A patient with thyroid carcinoma developed widespread bone and liver metastases with high radioiodine uptake.
- The patient presented with thyrotoxicosis, low iodine uptake in residual thyroid tissue, and suppressed TSH.
- Administration of 240 millicuries of radioactive iodine (131I) was given.
Findings:
- The 131I treatment resulted in hypothyroidism.
- Clinical regression of liver metastases was observed.
- Extra-cervical iodine uptake disappeared post-treatment.
Implications:
- High-dose radioiodine therapy can be effective for managing extensive thyroid cancer metastases.
- This approach can lead to remission of metastatic disease, albeit with induced hypothyroidism.
- Understanding iodine uptake patterns is crucial for effective treatment strategies in advanced thyroid carcinoma.